Synergistic Drug Targeting

Centrose is ushering in a new era of drug therapy by creating a revolutionary class of targeted therapeutics called EDCs. EDCs work by simultaneously targeting a pair of adjacent proteins found complexed only on specific disease causing cells. When these two proteins form a complex, both the drug portion and the targeting portion of the EDC binds simultaneously to their respective targets.  Only when this synergistic event occurs, does the EDC act on the cell. This unique system gives EDCs exquisite specificity, bringing both safety and potency.

At Centrose, our mission is to improve life by creating better drugs.